As the drug-pricing debate focuses on insulin for diabetes patients, Novo Nordisk launched its My$99Insulin Program, follow-on brands of insulins, and an Immediate Supply option.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,